Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -116,835 | -98,688 | -96,749 | -97,483 | -115,212 |
Depreciation Amortization | 18,523 | 18,435 | 14,156 | 9,819 | 6,875 |
Accounts receivable | 2,252 | -3,187 | -13,091 | -8,338 | -2,674 |
Accounts payable and accrued liabilities | -6,305 | 3,247 | 177 | 5,802 | 9,635 |
Other Working Capital | 48,858 | -5,723 | -12,297 | -21,828 | 11,654 |
Other Operating Activity | 28,761 | -1,528 | 3,242 | 31,766 | 20,580 |
Operating Cash Flow | $-24,746 | $-87,444 | $-104,562 | $-80,262 | $-69,142 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -13,363 | N/A | 15,000 | -6,706 | -19,692 |
PPE Investments | -1,073 | -2,431 | -18,543 | -45,639 | -12,499 |
Net Acquisitions | 79 | -446 | 10,979 | N/A | N/A |
Purchase Of Investment | 489 | 126 | -143 | -1,430 | -3,636 |
Purchase Sale Intangibles | N/A | -10 | -13 | -567 | -45 |
Other Investing Activity | -1,642 | -10 | -14 | -567 | -45 |
Investing Cash Flow | $-15,510 | $-2,761 | $7,279 | $-54,342 | $-35,872 |
Cash Flows From Financing Activities | |||||
Debt Issued | 29,671 | 5,750 | N/A | N/A | N/A |
Debt Repayment | -5,107 | -1,343 | N/A | 24,170 | N/A |
Common Stock Issued | 67,936 | -569 | 56,239 | 9,759 | -469 |
Other Financing Activity | -9,635 | -2,693 | -8,714 | -6,607 | -3,393 |
Financing Cash Flow | $82,865 | $1,145 | $47,525 | $27,322 | $-3,862 |
Exchange Rate Effect | 884 | -3,360 | -5,754 | 7,908 | -2,103 |
Beginning Cash Position | 93,216 | 185,636 | 241,148 | 340,522 | 451,501 |
End Cash Position | 136,708 | 93,216 | 185,636 | 241,148 | 340,522 |
Net Cash Flow | $43,492 | $-92,420 | $-55,512 | $-99,374 | $-110,979 |
Free Cash Flow | |||||
Operating Cash Flow | -24,746 | -87,444 | -104,562 | -80,262 | -69,142 |
Capital Expenditure | -1,073 | -2,431 | -18,543 | -45,693 | -12,913 |
Free Cash Flow | -25,819 | -89,875 | -123,105 | -125,955 | -82,055 |